The idea that the “treatment burden” affects a patient’s adherence to medications, adaptations and attending ongoing appointments, and is linked to worse medical outcomes, is emerging in healthcare literature (Alsadah et al, 2022). A wide range of chronic eye conditions and comorbidities with other diseases can have an impact on a patient’s quality of life. From drops and lasers for primary open angle glaucoma to intravitreal injections for eye conditions such as diabetic macular oedema, treatment burden can be relevant to a variety of medical interventions.